| Product Code: ETC10088061 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam mRNA Therapeutics Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam mRNA Therapeutics Market - Industry Life Cycle |
3.4 Vietnam mRNA Therapeutics Market - Porter's Five Forces |
3.5 Vietnam mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Vietnam mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Vietnam mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Vietnam mRNA Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Vietnam |
4.2.2 Growing investment in healthcare infrastructure and research development activities |
4.2.3 Rising awareness about personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 Limited availability and high cost of mRNA therapeutics in Vietnam |
4.3.2 Regulatory challenges and approval process for mRNA therapeutics |
4.3.3 Lack of skilled professionals and expertise in mRNA technology |
5 Vietnam mRNA Therapeutics Market Trends |
6 Vietnam mRNA Therapeutics Market, By Types |
6.1 Vietnam mRNA Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Vietnam mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F |
6.1.4 Vietnam mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F |
6.2 Vietnam mRNA Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Vietnam mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Vietnam mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F |
6.2.5 Vietnam mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.2.6 Vietnam mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Vietnam mRNA Therapeutics Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Vietnam mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Vietnam mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.4 Vietnam mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam mRNA Therapeutics Market Import-Export Trade Statistics |
7.1 Vietnam mRNA Therapeutics Market Export to Major Countries |
7.2 Vietnam mRNA Therapeutics Market Imports from Major Countries |
8 Vietnam mRNA Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on mRNA therapeutics in Vietnam |
8.2 Adoption rate of mRNA therapeutics by healthcare providers in Vietnam |
8.3 Investment in mRNA therapeutics-related startups and companies in Vietnam |
9 Vietnam mRNA Therapeutics Market - Opportunity Assessment |
9.1 Vietnam mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Vietnam mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Vietnam mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Vietnam mRNA Therapeutics Market - Competitive Landscape |
10.1 Vietnam mRNA Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Vietnam mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here